Thrombospondin (TSP) and Transforming Growth Factor β 1 (TGF-β) Promote Human A549 Lung Carcinoma Cell Plasminogen Activator Inhibitor Type 1 (Pal-1) Production and Stimulate Tumor Cell Attachment in Vitro

Daniel Albo, J. P. Arnoletti, A. Castiglioni, M. S. Granick, M. P. Solomon, V. L. Rothman, G. P. Tuszynski

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

A growing body of evidence has recently implicated TSP and TGF-β in the process of malignancy, such as tumor cell proliferation, tumor angiogenesis, and metastasis. The purpose of the present study was to evaluate potential mechanisms of TSP and TGF-β in tumor cell attachment and invasion. Our results indicate that both TSP and TGF-β promoted tumor cell attachment and spreading in the presence of plasminogen. The mechanism for these effects appeared to be due, in part, to the capacity of TSP and TGF-β to induce tumor cell production of (PAI-1). PAI-1, which is a natural inhibitor of tumor-cell associated urokinase-type plasminogen activator (uPA) activity, inhibited activation of plasminogen to plasmin in the growth media,thereby preventing plasmin-induced detachment of cells. The TSP-promoted production of PAI-1 could be inhibited not only by anti-TSP antibodies but also by a neutralizing antibody against TGF-β. These results suggest that TSP by a mechanism involving TGF-β can promote cell adhesion through stimulation of tumor cell secretion of PAI-1. These data provide evidence that TSP not only has the capacity of functioning as a matrix protein to directly promote cell-substratum adhesion but that TSP can also stimulate cell adhesion and spreading by modulating cell surface protease expression through stimulation of tumor-associated production of PAI-1.

Original languageEnglish (US)
Pages (from-to)857-865
Number of pages9
JournalBiochemical and Biophysical Research Communications
Volume203
Issue number2
DOIs
StatePublished - Sep 15 1994
Externally publishedYes

Fingerprint

Thrombospondins
Plasminogen Activator Inhibitor 1
Transforming Growth Factors
Tumors
Cells
Carcinoma
Lung
Neoplasms
Cell adhesion
Cell Adhesion
Plasminogen
Fibrinolysin
In Vitro Techniques
Urokinase-Type Plasminogen Activator
Cell proliferation
Neutralizing Antibodies
Anti-Idiotypic Antibodies
Peptide Hydrolases
Chemical activation
Cell Proliferation

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Thrombospondin (TSP) and Transforming Growth Factor β 1 (TGF-β) Promote Human A549 Lung Carcinoma Cell Plasminogen Activator Inhibitor Type 1 (Pal-1) Production and Stimulate Tumor Cell Attachment in Vitro. / Albo, Daniel; Arnoletti, J. P.; Castiglioni, A.; Granick, M. S.; Solomon, M. P.; Rothman, V. L.; Tuszynski, G. P.

In: Biochemical and Biophysical Research Communications, Vol. 203, No. 2, 15.09.1994, p. 857-865.

Research output: Contribution to journalArticle

@article{33831fff255c489293c335bf3c0868ca,
title = "Thrombospondin (TSP) and Transforming Growth Factor β 1 (TGF-β) Promote Human A549 Lung Carcinoma Cell Plasminogen Activator Inhibitor Type 1 (Pal-1) Production and Stimulate Tumor Cell Attachment in Vitro",
abstract = "A growing body of evidence has recently implicated TSP and TGF-β in the process of malignancy, such as tumor cell proliferation, tumor angiogenesis, and metastasis. The purpose of the present study was to evaluate potential mechanisms of TSP and TGF-β in tumor cell attachment and invasion. Our results indicate that both TSP and TGF-β promoted tumor cell attachment and spreading in the presence of plasminogen. The mechanism for these effects appeared to be due, in part, to the capacity of TSP and TGF-β to induce tumor cell production of (PAI-1). PAI-1, which is a natural inhibitor of tumor-cell associated urokinase-type plasminogen activator (uPA) activity, inhibited activation of plasminogen to plasmin in the growth media,thereby preventing plasmin-induced detachment of cells. The TSP-promoted production of PAI-1 could be inhibited not only by anti-TSP antibodies but also by a neutralizing antibody against TGF-β. These results suggest that TSP by a mechanism involving TGF-β can promote cell adhesion through stimulation of tumor cell secretion of PAI-1. These data provide evidence that TSP not only has the capacity of functioning as a matrix protein to directly promote cell-substratum adhesion but that TSP can also stimulate cell adhesion and spreading by modulating cell surface protease expression through stimulation of tumor-associated production of PAI-1.",
author = "Daniel Albo and Arnoletti, {J. P.} and A. Castiglioni and Granick, {M. S.} and Solomon, {M. P.} and Rothman, {V. L.} and Tuszynski, {G. P.}",
year = "1994",
month = "9",
day = "15",
doi = "10.1006/bbrc.1994.2262",
language = "English (US)",
volume = "203",
pages = "857--865",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Thrombospondin (TSP) and Transforming Growth Factor β 1 (TGF-β) Promote Human A549 Lung Carcinoma Cell Plasminogen Activator Inhibitor Type 1 (Pal-1) Production and Stimulate Tumor Cell Attachment in Vitro

AU - Albo, Daniel

AU - Arnoletti, J. P.

AU - Castiglioni, A.

AU - Granick, M. S.

AU - Solomon, M. P.

AU - Rothman, V. L.

AU - Tuszynski, G. P.

PY - 1994/9/15

Y1 - 1994/9/15

N2 - A growing body of evidence has recently implicated TSP and TGF-β in the process of malignancy, such as tumor cell proliferation, tumor angiogenesis, and metastasis. The purpose of the present study was to evaluate potential mechanisms of TSP and TGF-β in tumor cell attachment and invasion. Our results indicate that both TSP and TGF-β promoted tumor cell attachment and spreading in the presence of plasminogen. The mechanism for these effects appeared to be due, in part, to the capacity of TSP and TGF-β to induce tumor cell production of (PAI-1). PAI-1, which is a natural inhibitor of tumor-cell associated urokinase-type plasminogen activator (uPA) activity, inhibited activation of plasminogen to plasmin in the growth media,thereby preventing plasmin-induced detachment of cells. The TSP-promoted production of PAI-1 could be inhibited not only by anti-TSP antibodies but also by a neutralizing antibody against TGF-β. These results suggest that TSP by a mechanism involving TGF-β can promote cell adhesion through stimulation of tumor cell secretion of PAI-1. These data provide evidence that TSP not only has the capacity of functioning as a matrix protein to directly promote cell-substratum adhesion but that TSP can also stimulate cell adhesion and spreading by modulating cell surface protease expression through stimulation of tumor-associated production of PAI-1.

AB - A growing body of evidence has recently implicated TSP and TGF-β in the process of malignancy, such as tumor cell proliferation, tumor angiogenesis, and metastasis. The purpose of the present study was to evaluate potential mechanisms of TSP and TGF-β in tumor cell attachment and invasion. Our results indicate that both TSP and TGF-β promoted tumor cell attachment and spreading in the presence of plasminogen. The mechanism for these effects appeared to be due, in part, to the capacity of TSP and TGF-β to induce tumor cell production of (PAI-1). PAI-1, which is a natural inhibitor of tumor-cell associated urokinase-type plasminogen activator (uPA) activity, inhibited activation of plasminogen to plasmin in the growth media,thereby preventing plasmin-induced detachment of cells. The TSP-promoted production of PAI-1 could be inhibited not only by anti-TSP antibodies but also by a neutralizing antibody against TGF-β. These results suggest that TSP by a mechanism involving TGF-β can promote cell adhesion through stimulation of tumor cell secretion of PAI-1. These data provide evidence that TSP not only has the capacity of functioning as a matrix protein to directly promote cell-substratum adhesion but that TSP can also stimulate cell adhesion and spreading by modulating cell surface protease expression through stimulation of tumor-associated production of PAI-1.

UR - http://www.scopus.com/inward/record.url?scp=0028074217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028074217&partnerID=8YFLogxK

U2 - 10.1006/bbrc.1994.2262

DO - 10.1006/bbrc.1994.2262

M3 - Article

VL - 203

SP - 857

EP - 865

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -